551Effects of interleukin-33 on tissue factor in human endothelial cells in vitro

    loading  Checking for direct PDF access through Ovid


Background: Interleukin (IL)-33 is a member of the IL-1 cytokine family. IL-33 was previously shown to induce angiogenesis and the expression of inflammatory cytokines and adhesion molecules in endothelial cells. Tissue factor (TF) is a primary trigger of coagulation. Elevated levels of TF are found in atherosclerotic plaques, and TF leads to thrombus formation, when released upon plaque rupture.

Aim: Here we investigated the impact of IL-33 on TF expression in human endothelial cells, as a new possible mechanism for IL-33 to regulate their thrombotic potential.

Methods and Results: Human umbilical vein endothelial cells (HUVEC) and human coronary artery endothelial cells (HCAEC) were treated with 100, 10 and 1ng/ml recombinant human IL-33. Expression of mRNA specific for TF was determined by RT-PCR. TF protein levels were measured by specific enzyme-linked immunosorbent assays (ELISAs). We found that IL-33 significantly induced TF mRNA up to 200-fold and protein expression up to 145-fold in a time- and concentration-dependent manner in HUVEC and HCAEC. ST2-siRNA-mediated gene knockdown inhibited IL-33-induced TF expression, suggesting that this effect of IL-33 is facilitated through its receptor ST2. Preincubation of HUVEC with 100μM of the NFkB-inhibitor dimethyl-fumarate abrogated IL-33-induced TF protein synthesis. IL-1 receptor antagonist had no effect on IL-33-induced increase of TF expression. In human carotid atherosclerotic plaques (n=16), TF mRNA positively correlated with IL-33 mRNA expression (r=0.86, p<0.001).

Conclusion: Our results showed that IL-33 increases TF expression in human endothelial cells, and that this effect is ST2/NFkB-dependent, but IL-1-independent. Furthermore, we supported our in vitro data in human atherosclerotic tissue where we found a strong positive correlation of IL-33 and TF expression. Thus, IL-33-induced changes in TF expression could affect the thrombotic potential of endothelial cells, as well as potentiate thrombotic events in the setting of ruptured human atherosclerotic plaques.

Related Topics

    loading  Loading Related Articles